Are cannabis users who participate in a randomized clinical trial different from other treatment seekers?

Journal of Substance Abuse Treatment

Volumn 36, Issue 3, 2009, Pages 339-344

  Frewen, Amie R ^a,b,c   Baillie, Andrew J ^a   Montebello, Mark E ^b,c  

^a MACQUARIE UNIVERSITY   (Australia)

^b Langton Centre   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Adults; Cannabis; Randomized control trial; Treatment seekers

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; ARTICLE; CANNABIS ADDICTION; COMORBIDITY; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; LEGAL ASPECT; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CRIME; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MENTAL DISORDERS; MIDDLE AGED; NEW SOUTH WALES; PATIENT ACCEPTANCE OF HEALTH CARE; PROGNOSIS; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 61349142437     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2008.07.004     Document Type: Article

References (28)

1. Andersen R. Revisiting the behavioral model and access to medical care: Does it matter?. Journal of Health and Social Behavior 36 (1995) 1-10
2. Andersen R., and Newman J.F. Societal and individual determinants of medical care utilization in the United States. Milbank Memorial Fund Quarterly 51 (1973) 95-124
3. Anthony J.C., Warner L.A., and Kessler R. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology 2 (1994) 224-268
4. Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2005-06: Report on the National Minimum Data Set. Drug treatment data briefing (2007), Australian Institute of Health & Welfare, Canberra
5. Australian Institute of Health and Welfare. 2007 National Drug Strategy Household Survey: first results. Drug Statistics Series number 20.Cat. no. PHE 98 (2008), AIHW, Canberra
6. Black E. Preliminary findings from the 2007 IDRS. Presented at 2007 National Drug Trends Conference Monday 15th October 2007. Sydney, National Drug & Alcohol Research Centre (2007)
7. Britton A., McKee M., Black N., McPherson K., Sanderson C., and Bain C. Threats to applicability of randomized trials: Exclusions and selective participation. Journal of Health Services & Research Policy 4 (1999) 112-121
8. Copeland J., Swift W., and Rees V.W. Clinical profile of participants in a brief intervention program for cannabis use disorder. Journal of Substance Abuse Treatment 20 (2001) 45-52
9. Copeland J., Swift W., Roffman R., and Stephens R. A randomized controlled trial of brief cognitive-behavioural interventions for cannabis use disorder. Journal of Substance Abuse Treatment 21 (2001) 55-64
10. Degenhardt L., Hall W., and Lynskey M. Exploring the association between cannabis use and depression. Addiction 98 (2003) 1493-1504
11. Epstein J. Substance dependence, abuse and treatment: Findings from the 2000 National Household Survey on Drug Abuse. Substance Abuse and Mental Health Services (2002), Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD. http://www.oas.samhsa.gov/analytic.htm Also available at
12. Goldberg D., and Huxley P. Common mental disorders: A bio-social model (1992), Routledge, London
13. Goldberg D., and Huxley P.J. Mental illness in the community: The pathway to psychiatric care (1980), Tavistock Publications, London
14. Grant B. Toward an alcohol treatment model: A comparison of treatment and untreated respondents with DSM-IV alcohol use disorders in the general population. Alcoholism: Clinical and Experimental Research 20 (1996) 372-378
15. Huxley P.J. Mental illness in the community: The Goldberg-Huxley model of the pathway to psychiatric care. Nordic Journal of Psychiatry 50 (1996) 47-53
16. Issakidis C., and Andrews G. Who treats whom? An application of the Pathways to Care model in Australia. Australian & New Zealand Journal of Psychiatry 40 (2006) 74-86
17. Kessler R., Nelson C., McGonagle K., Edlund M., Frank R., and Leaf P. The epidemiology of co-occurring addictive and mental disorders: implication for prevention and service utilization. American Journal of Orthopsychiatry 66 (1996) 17-31
18. Licht R. Limitations in randomized controlled trials evaluating drug effects in mania. European Archives of Psychiatry and Clinical Neuroscience 251 (2001) 66-71
19. Licht R., Gouliaev G., and Per F. Generalisability of results from randomised drug trials: A trial on antimanic treatment. British Journal of Psychiatry 170 (1997) 264-267
20. Rapp R., Xu J., Carr C., Lane T., Wang J., and Carlson R. Treatment barriers identified by substance abusers assessed at a centralized intake unit. Journal of Substance Abuse Treatment 30 (2006) 227-235
21. Reilly D., Didcott P., Swift W., and Hall W. Long-term cannabis users on the New South Wales North Coast, NDARC Monograph No. 30 (1997), National Drug & Alcohol Research Centre, Sydney
22. Ross H., and Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Archives of General Psychiatry 45 (1988) 1023-1031
23. Rush B., and Urbanoski K. Estimating the demand for treatment for cannabis-related problems in Canada. International Journal of Mental Health and Addiction 5 (2007) 181-186
24. Saunders S., Zygowicz K., and D'Angelo B. Person-related and treatment-related barriers to alcohol treatment. Journal of Substance Abuse Treatment 30 (2006) 261-270
25. Stirman S., DeRubeis R., Crits-Christoph P., and Rothman A. Can the randomized controlled trial literature generalize to nonrandomized patients?. Journal of Consulting and Clinical Psychology 73 (2005) 127-135
26. Stephens R., Roffman R., and Simpson E. Adult marijuana users seeking treatment. Journal of Consulting and Clinical Psychology 61 (1993) 1100-1104
27. Treloar C., Abelson J., Cao W., Brener L., Kippax S., Schultz L., et al. Monograph series no. 53. Barriers and incentives to treatment for illicit drugs users (2004), Commonwealth of Australia, Canberra
28. Tsogia D., Copello A., and Orford J. Entering treatment for substance misuse: A review of the literature. Journal of Mental Health 10 (2001) 481-499